Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,834	Closed	-$123K	–	41
2017 Q4	$123K	Sell	2,834 -70,750	-96%	-$3.01M	0.05%	30
2017 Q3	$3.1M	Buy	73,584 +1,130	+2%	+$47.9K	1.21%	19
2017 Q2	$3.13M	Buy	72,454 +70,750	+4,152%	+$2.98M	1.2%	21
2017 Q1	$72K	Buy	+1,704	New	+$69.4K	0.03%	32
2016 Q4	–	Sell	-107,450	Closed	-$4.75M	–	38
2016 Q3	$4.75M	Hold	107,450	–	–	1.85%	21
2016 Q2	$4.49M	Hold	107,450	–	–	1.62%	23
2016 Q1	$4.32M	Hold	107,450	–	–	1.52%	24
2015 Q4	$5.5M	Buy	+107,450	New	+$5.48M	1.44%	26

Other funds holding XPH

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Arnhold LLC New York $1.43B AUM 59.3% 1-Year Est. Return

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's XPH Position: Q1 2018 in Review

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2018, closing a stake of 2,834 shares — an estimated $123K sold.

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet first reported a position in XPH in Q4 2015 and held it in 8 quarters. The position peaked at $5.5M in Q4 2015. 75 funds tracked by Wall St. Rank hold XPH as of Q1 2018.

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2018 after selling out during the quarter.
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet sold 2,834 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2018, an estimated $123K.
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2015 and held it in 8 quarters.
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's State Street SPDR S&P Pharmaceuticals ETF position peaked at $5.5M in Q4 2015.
75 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2018.

Based on Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's 13F filing for Q1 2018, filed 15 May 2018.